ReP USP - Resultado da busca

Artigo de periodico
Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients (2015)
Kamkhagi, Dorli; Costa, Ana Carolina Oliveira; Kusminsky, Sandra; Supino, Deborah; Diniz, Breno Satler; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: Archives of clinical psychiatry. Unidade: FM
Subjects: DEPRESSÃO, DEMENTIA (REABILITAÇÃO;TERAPIA), DOENÇA DE ALZHEIMER, PSICOTERAPIA DE GRUPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAMKHAGI, Dorli et al. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients. Archives of clinical psychiatry, v. 42, n. 5-6, p. 157-160, 2015Tradução . . Disponível em: https://doi.org/10.1590/0101-60830000000067. Acesso em: 15 nov. 2024.
APA
Kamkhagi, D., Costa, A. C. O., Kusminsky, S., Supino, D., Diniz, B. S., Gattaz, W. F., & Forlenza, O. V. (2015). Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients. Archives of clinical psychiatry, 42( 5-6), 157-160. doi:10.1590/0101-60830000000067
NLM
Kamkhagi D, Costa ACO, Kusminsky S, Supino D, Diniz BS, Gattaz WF, Forlenza OV. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients [Internet]. Archives of clinical psychiatry. 2015 ; 42( 5-6): 157-160.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1590/0101-60830000000067
Vancouver
Kamkhagi D, Costa ACO, Kusminsky S, Supino D, Diniz BS, Gattaz WF, Forlenza OV. Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients [Internet]. Archives of clinical psychiatry. 2015 ; 42( 5-6): 157-160.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1590/0101-60830000000067
Artigo de periodico
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease (2015)
Forlenza, Orestes Vicente; Diniz, Breno Satler; Teixeira, Antonio Lucio; Radanovic, Marcia; Talib, Leda Leme; Rocha, Natalia Pessoa; Gattaz, Wagner Farid
Source: Neuromolecular Medicine. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, INFLAMAÇÃO, BIOMARCADORES, DOENÇAS NEURODEGENERATIVAS (FISIOPATOLOGIA), LÍQUIDO CEFALORRAQUIDIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes Vicente et al. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Neuromolecular Medicine, v. 17, n. 3, p. 326-332, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s12017-015-8361-y. Acesso em: 15 nov. 2024.
APA
Forlenza, O. V., Diniz, B. S., Teixeira, A. L., Radanovic, M., Talib, L. L., Rocha, N. P., & Gattaz, W. F. (2015). Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Neuromolecular Medicine, 17( 3), 326-332. doi:10.1007/s12017-015-8361-y
NLM
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2015 ; 17( 3): 326-332.[citado 2024 nov. 15 ] Available from: http://link.springer.com/article/10.1007/s12017-015-8361-y
Vancouver
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2015 ; 17( 3): 326-332.[citado 2024 nov. 15 ] Available from: http://link.springer.com/article/10.1007/s12017-015-8361-y
Artigo de periodico
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders (2013)
Diniz, Breno Satler; Machado-Vieira, Rodrigo; Forlenza, Orestes Vicente
Source: Neuropsychiatric disease and treatment. Unidade: FM
Subjects: LÍTIO (FARMACOLOGIA;USO TERAPÊUTICO), ESTRESSE OXIDATIVO, TRANSTORNOS NEUROPSICOLÓGICOS, DOENÇA DE ALZHEIMER (PREVENÇÃO E CONTROLE), NEUROPSIQUIATRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Breno Satler e MACHADO-VIEIRA, Rodrigo e FORLENZA, Orestes Vicente. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatric disease and treatment, v. 9, p. 493-500, 2013Tradução . . Disponível em: https://doi.org/10.2147/NDT.S33086. Acesso em: 15 nov. 2024.
APA
Diniz, B. S., Machado-Vieira, R., & Forlenza, O. V. (2013). Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatric disease and treatment, 9, 493-500. doi:10.2147/NDT.S33086
NLM
Diniz BS, Machado-Vieira R, Forlenza OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders [Internet]. Neuropsychiatric disease and treatment. 2013 ; 9 493-500.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2147/NDT.S33086
Vancouver
Diniz BS, Machado-Vieira R, Forlenza OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders [Internet]. Neuropsychiatric disease and treatment. 2013 ; 9 493-500.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2147/NDT.S33086
Artigo de periodico
Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains (2011)
Aprahamian, Ivan; Diniz, Breno Satler; Izbicki, Rafael; Radanovic, Márcia; Nunes, Paula Villela; Forlenza, Orestes Vicente
Source: International Journal of Geriatric Psychiatry. Unidade: FM
Subjects: TRANSTORNOS COGNITIVOS, FATORES DE RISCO, DEMÊNCIA, DOENÇA DE ALZHEIMER (COMPLICAÇÕES), TESTES NEUROPSICOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APRAHAMIAN, Ivan et al. Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains. International Journal of Geriatric Psychiatry, v. 26, n. 4, p. 403-408, 2011Tradução . . Disponível em: https://doi.org/10.1002/gps.2540. Acesso em: 15 nov. 2024.
APA
Aprahamian, I., Diniz, B. S., Izbicki, R., Radanovic, M., Nunes, P. V., & Forlenza, O. V. (2011). Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains. International Journal of Geriatric Psychiatry, 26( 4), 403-408. doi:10.1002/gps.2540
NLM
Aprahamian I, Diniz BS, Izbicki R, Radanovic M, Nunes PV, Forlenza OV. Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains [Internet]. International Journal of Geriatric Psychiatry. 2011 ; 26( 4): 403-408.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1002/gps.2540
Vancouver
Aprahamian I, Diniz BS, Izbicki R, Radanovic M, Nunes PV, Forlenza OV. Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains [Internet]. International Journal of Geriatric Psychiatry. 2011 ; 26( 4): 403-408.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1002/gps.2540
Artigo de periodico
Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients (2010)
Diniz, Breno Satler; Teixeira, Antonio Lucio; Talib, Leda; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: American journal of geriatric psychiatry. Unidade: FM
Subjects: IDOSOS, VELHICE, COGNIÇÃO (AVALIAÇÃO), INTERLEUCINAS (USO TERAPÊUTICO), DEPRESSÃO (TERAPIA), ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Breno Satler et al. Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients. American journal of geriatric psychiatry, v. 18, n. 2, p. 172-176, 2010Tradução . . Disponível em: https://doi.org/10.1097/JGP.0b013e3181c2947f. Acesso em: 15 nov. 2024.
APA
Diniz, B. S., Teixeira, A. L., Talib, L., Gattaz, W. F., & Forlenza, O. V. (2010). Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients. American journal of geriatric psychiatry, 18( 2), 172-176. doi:10.1097/JGP.0b013e3181c2947f
NLM
Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV. Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients [Internet]. American journal of geriatric psychiatry. 2010 ; 18( 2): 172-176.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1097/JGP.0b013e3181c2947f
Vancouver
Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV. Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients [Internet]. American journal of geriatric psychiatry. 2010 ; 18( 2): 172-176.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1097/JGP.0b013e3181c2947f
Artigo de periodico
Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression (2010)
Diniz, Breno Satler; Teixeira, Antonio Lucio; Talib, Leda Leme; Mendonça, Vanessa Amaral; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: Journal of Psychiatric Research. Unidade: FM
Subjects: ANTIDEPRESSIVOS (USO TERAPÊUTICO), DEPRESSÃO (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Breno Satler et al. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. Journal of Psychiatric Research, v. 44, n. 14, p. 917-920, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2010.02.008. Acesso em: 15 nov. 2024.
APA
Diniz, B. S., Teixeira, A. L., Talib, L. L., Mendonça, V. A., Gattaz, W. F., & Forlenza, O. V. (2010). Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. Journal of Psychiatric Research, 44( 14), 917-920. doi:10.1016/j.jpsychires.2010.02.008
NLM
Diniz BS, Teixeira AL, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression [Internet]. Journal of Psychiatric Research. 2010 ; 44( 14): 917-920.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2010.02.008
Vancouver
Diniz BS, Teixeira AL, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression [Internet]. Journal of Psychiatric Research. 2010 ; 44( 14): 917-920.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2010.02.008
Artigo de periodico
Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults (2010)
Pereira, Fernanda Speggiorin; Oliveira, Alexandra Martini de; Diniz, Breno Satler; Forlenza, Orestes Vicente; Yassuda, Mônica Sanches
Source: Archives of Clinical Neuropsychology. Unidades: FM, EACH
Subjects: DOENÇA DE ALZHEIMER (AVALIAÇÃO), DEMÊNCIA SENIL (AVALIAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Fernanda Speggiorin et al. Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. Archives of Clinical Neuropsychology, v. 25, n. ju 2010, p. 335-343, 2010Tradução . . Disponível em: http://acn.oxfordjournals.org/content/25/4/335.full.pdf+html. Acesso em: 15 nov. 2024.
APA
Pereira, F. S., Oliveira, A. M. de, Diniz, B. S., Forlenza, O. V., & Yassuda, M. S. (2010). Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults. Archives of Clinical Neuropsychology, 25( ju 2010), 335-343. Recuperado de http://acn.oxfordjournals.org/content/25/4/335.full.pdf+html
NLM
Pereira FS, Oliveira AM de, Diniz BS, Forlenza OV, Yassuda MS. Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults [Internet]. Archives of Clinical Neuropsychology. 2010 ; 25( ju 2010): 335-343.[citado 2024 nov. 15 ] Available from: http://acn.oxfordjournals.org/content/25/4/335.full.pdf+html
Vancouver
Pereira FS, Oliveira AM de, Diniz BS, Forlenza OV, Yassuda MS. Cross-cultural adaptation, reliability and validity of the DAFS-R in a sample of Brazilian older adults [Internet]. Archives of Clinical Neuropsychology. 2010 ; 25( ju 2010): 335-343.[citado 2024 nov. 15 ] Available from: http://acn.oxfordjournals.org/content/25/4/335.full.pdf+html
Artigo de periodico
Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment (2010)
Forlenza, Orestes Vicente; Diniz, Breno Satler; Talib, Leda Leme; Radanovic, Marcia; Yassuda, Mônica Sanches; Ojopi, Elida Paula Benquique; Gattaz, Wagner Farid
Source: Revista Brasileira de Psiquiatria. Unidades: FM, EACH
Subjects: DOENÇA DE ALZHEIMER, TRANSTORNOS COGNITIVOS, PROCEDIMENTOS CLÍNICOS, MANIFESTAÇÕES NEUROCOMPORTAMENTAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORLENZA, Orestes Vicente et al. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Revista Brasileira de Psiquiatria, v. 32, n. 3, p. 216-222, 2010Tradução . . Disponível em: https://doi.org/10.1590/S1516-44462010005000002. Acesso em: 15 nov. 2024.
APA
Forlenza, O. V., Diniz, B. S., Talib, L. L., Radanovic, M., Yassuda, M. S., Ojopi, E. P. B., & Gattaz, W. F. (2010). Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Revista Brasileira de Psiquiatria, 32( 3), 216-222. doi:10.1590/S1516-44462010005000002
NLM
Forlenza OV, Diniz BS, Talib LL, Radanovic M, Yassuda MS, Ojopi EPB, Gattaz WF. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment [Internet]. Revista Brasileira de Psiquiatria. 2010 ; 32( 3): 216-222.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1590/S1516-44462010005000002
Vancouver
Forlenza OV, Diniz BS, Talib LL, Radanovic M, Yassuda MS, Ojopi EPB, Gattaz WF. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment [Internet]. Revista Brasileira de Psiquiatria. 2010 ; 32( 3): 216-222.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1590/S1516-44462010005000002
Artigo de periodico
Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education (2009)
Radanovic, Marcia; Diniz, Breno Satler; Mirandez, Roberta M.; Novaretti, Tânia Maria da Silva; Flacks, Mariana Kneese; Yassuda, Monica Sanches; Forlenza, Orestes Vicente
Source: International Psychogeriatrics. Unidade: FM
Subjects: TRANSTORNOS COGNITIVOS, DOENÇA DE ALZHEIMER, IDOSOS, DEMÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RADANOVIC, Marcia et al. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education. International Psychogeriatrics, v. 21, n. 6, p. 1081-1087, 2009Tradução . . Disponível em: https://doi.org/10.1017/s1041610209990639. Acesso em: 15 nov. 2024.
APA
Radanovic, M., Diniz, B. S., Mirandez, R. M., Novaretti, T. M. da S., Flacks, M. K., Yassuda, M. S., & Forlenza, O. V. (2009). Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education. International Psychogeriatrics, 21( 6), 1081-1087. doi:10.1017/s1041610209990639
NLM
Radanovic M, Diniz BS, Mirandez RM, Novaretti TM da S, Flacks MK, Yassuda MS, Forlenza OV. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education [Internet]. International Psychogeriatrics. 2009 ; 21( 6): 1081-1087.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1017/s1041610209990639
Vancouver
Radanovic M, Diniz BS, Mirandez RM, Novaretti TM da S, Flacks MK, Yassuda MS, Forlenza OV. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education [Internet]. International Psychogeriatrics. 2009 ; 21( 6): 1081-1087.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1017/s1041610209990639
Artigo de periodico
To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease (2009)
Diniz, Breno Satler; Pinto Junior, Jony Arrais; Gonzaga, Maria Luiza Cavichioli; Guimarães, Fabiana Meira; Gattaz, Wagner Farid; Forlenza, Orestes Vicente
Source: European Archives of Psychiatry and Clinical Neurosciences. Unidade: FM
Subjects: METANÁLISE, DOENÇA DE ALZHEIMER, EVOLUÇÃO CLÍNICA, TRANSTORNOS COGNITIVOS (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DINIZ, Breno Satler et al. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease. European Archives of Psychiatry and Clinical Neurosciences, v. 259, n. 4, p. 248-256, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00406-008-0864-1. Acesso em: 15 nov. 2024.
APA
Diniz, B. S., Pinto Junior, J. A., Gonzaga, M. L. C., Guimarães, F. M., Gattaz, W. F., & Forlenza, O. V. (2009). To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease. European Archives of Psychiatry and Clinical Neurosciences, 259( 4), 248-256. doi:10.1007/s00406-008-0864-1
NLM
Diniz BS, Pinto Junior JA, Gonzaga MLC, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease [Internet]. European Archives of Psychiatry and Clinical Neurosciences. 2009 ; 259( 4): 248-256.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00406-008-0864-1
Vancouver
Diniz BS, Pinto Junior JA, Gonzaga MLC, Guimarães FM, Gattaz WF, Forlenza OV. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease [Internet]. European Archives of Psychiatry and Clinical Neurosciences. 2009 ; 259( 4): 248-256.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s00406-008-0864-1
Artigo de periodico
Neurobiological pathways to Alzheimer's disease: amyloid-beta, Tau protein or both? (2009)
Paula, Vanessa de Jesus R. de; Guimarães, Fabiana Meira; Diniz, Breno Satler; Forlenza, Orestes Vicente
Source: Dementia & Neuropsychologia. Unidade: FM
Subjects: DOENÇA DE ALZHEIMER, NEUROBIOLOGIA, PROTEÍNAS (ANÁLISE)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAULA, Vanessa de Jesus R. de et al. Neurobiological pathways to Alzheimer's disease: amyloid-beta, Tau protein or both?. Dementia & Neuropsychologia, v. 3, n. 3 p. 188-194, 2009Tradução . . Disponível em: https://doi.org/10.1590/s1980-57642009dn30300003. Acesso em: 15 nov. 2024.
APA
Paula, V. de J. R. de, Guimarães, F. M., Diniz, B. S., & Forlenza, O. V. (2009). Neurobiological pathways to Alzheimer's disease: amyloid-beta, Tau protein or both? Dementia & Neuropsychologia, 3( 3 p. 188-194). doi:10.1590/s1980-57642009dn30300003
NLM
Paula V de JR de, Guimarães FM, Diniz BS, Forlenza OV. Neurobiological pathways to Alzheimer's disease: amyloid-beta, Tau protein or both? [Internet]. Dementia & Neuropsychologia. 2009 ; 3( 3 p. 188-194):[citado 2024 nov. 15 ] Available from: https://doi.org/10.1590/s1980-57642009dn30300003
Vancouver
Paula V de JR de, Guimarães FM, Diniz BS, Forlenza OV. Neurobiological pathways to Alzheimer's disease: amyloid-beta, Tau protein or both? [Internet]. Dementia & Neuropsychologia. 2009 ; 3( 3 p. 188-194):[citado 2024 nov. 15 ] Available from: https://doi.org/10.1590/s1980-57642009dn30300003

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Indexado em